Time interval between the onset of connective tissue disease symptoms and first contact with a rheumatologist: results from the German National Database of collaborative arthritis centers.

Connective tissue disease Diagnosis Sjögrens syndrome Systemic lupus erythematosus Systemic sclerosis

Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
08 2023
Historique:
received: 28 11 2022
accepted: 20 04 2023
medline: 14 6 2023
pubmed: 1 6 2023
entrez: 31 5 2023
Statut: ppublish

Résumé

The long-term outcome of connective tissue diseases is associated with the time from symptom onset to diagnosis. To understand gaps in care, we determine whether the length of time between symptom onset and first presentation to a rheumatologist has changed in Germany in recent decades. We analyzed data on patients diagnosed with connective tissue diseases (n = 19,662) collected from the German National Database of the Regional Cooperative Rheumatology Centers. We reviewed the onset of relevant symptoms listed at first presentations from 1993 to 2018 and performed a quantitative analysis of the intervals until first presentation to a rheumatologist. We compared time intervals and performed a linear mixed regression model with random effects to identify associated factors. Although the interval between the onset of symptoms and first presentation to a rheumatologist has diminished since 1980 for all connective tissue diseases, there has been no relevant improvement during the past 2 decades. The interval between symptoms and presentation increases with patients age for all connective tissue diseases (e.g., Systemic sclerosis; for each 10-year-increment of patients age: β 0.41, CI 0.38; 0.44). Among those diagnosed with systemic sclerosis, the mean interval was 1.5 years (95% CI 1.1; 1.8) for male patients and 2.6 years (95% CI 2.4; 2.8) for females. Patients presenting with different degrees of disease severity on their first visits and with different educational levels had similar mean intervals between symptoms and first presentation regardless of their final diagnoses. Over the past 2 decades, the time to first consultation with a rheumatologist has not continued to improve in Germany, but has stagnated at the same level. Selected patient subgroups, such as older patients with suspected connective tissue diseases and female patients with suspected systemic sclerosis, are at risk to present late and may in particular benefit from an earlier referral to a rheumatologist.

Identifiants

pubmed: 37258745
doi: 10.1007/s00296-023-05335-0
pii: 10.1007/s00296-023-05335-0
pmc: PMC10261230
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1453-1458

Informations de copyright

© 2023. The Author(s).

Références

Appl Health Econ Health Policy. 2014 Apr;12(2):179-90
pubmed: 24573911
J Clin Med. 2021 Jan 11;10(2):
pubmed: 33440874
Autoimmun Rev. 2010 Nov;10(1):55-60
pubmed: 20813207
Lupus. 2017 Sep;26(10):1095-1100
pubmed: 28406053
Lupus. 2012 Sep;21(10):1135-48
pubmed: 22652632
Lupus. 2010 Jul;19(8):949-56
pubmed: 20375124
Rheumatol Int. 2019 Nov;39(11):1961-1970
pubmed: 31254002
Z Rheumatol. 2019 Dec;78(Suppl 2):65-72
pubmed: 31407089
Rheumatology (Oxford). 2020 Jun 1;59(6):1226-1232
pubmed: 31539063
Arthritis Rheum. 2009 Feb 15;61(2):274-8
pubmed: 19177534
Lupus Sci Med. 2017 Feb 10;4(1):e000172
pubmed: 28243454
Clin Rheumatol. 2017 Jan;36(1):89-95
pubmed: 27858177
Lupus. 2018 Apr;27(4):681-687
pubmed: 29310537
Acta Med Okayama. 2003 Aug;57(4):187-90
pubmed: 14627070

Auteurs

Anna Kernder (A)

Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40224, Düsseldorf, Germany.

Katja Thiele (K)

German Rheumatism Research Centre Berlin (DRFZ), Charitéplatz 1, 10117, Berlin (Mitte), Germany.

Gamal Chehab (G)

Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany. gamal.chehab@med.uni-duesseldorf.de.
Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40224, Düsseldorf, Germany. gamal.chehab@med.uni-duesseldorf.de.

Matthias Schneider (M)

Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40224, Düsseldorf, Germany.

Johanna Callhoff (J)

German Rheumatism Research Centre Berlin (DRFZ), Charitéplatz 1, 10117, Berlin (Mitte), Germany.
Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH